278 related articles for article (PubMed ID: 31620871)
1. The impact of inflammation on neurocognition and risk for psychosis: a critical review.
Kogan S; Ospina LH; Mittal VA; Kimhy D
Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):793-802. PubMed ID: 31620871
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.
Velthorst E; Meyer EC; Giuliano AJ; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Seidman LJ
Schizophr Res; 2019 Feb; 204():311-319. PubMed ID: 30078717
[TBL] [Abstract][Full Text] [Related]
3. Metacognition strengthens the association between neurocognition and attenuated psychosis syndrome: Preliminary evidence from a pilot study among treatment-seeking versus healthy adolescents.
Koren D; Scheyer R; Stern Y; Adres M; Reznik N; Apter A; Seidman LJ
Schizophr Res; 2019 Aug; 210():207-214. PubMed ID: 30630704
[TBL] [Abstract][Full Text] [Related]
4. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
[TBL] [Abstract][Full Text] [Related]
6. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.
Meyer EC; Carrión RE; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Heinssen R; Seidman LJ;
Schizophr Bull; 2014 Nov; 40(6):1452-61. PubMed ID: 24550526
[TBL] [Abstract][Full Text] [Related]
7. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
[TBL] [Abstract][Full Text] [Related]
8. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
Carrión RE; McLaughlin D; Auther AM; Olsen R; Correll CU; Cornblatt BA
Psychol Med; 2015 Nov; 45(15):3341-54. PubMed ID: 26169626
[TBL] [Abstract][Full Text] [Related]
9. Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis.
Loewy R; Fisher M; Schlosser DA; Biagianti B; Stuart B; Mathalon DH; Vinogradov S
Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S118-26. PubMed ID: 26903238
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
Chu AOK; Chang WC; Chan SKW; Lee EHM; Hui CLM; Chen EYH
Psychol Med; 2019 Aug; 49(11):1929-1936. PubMed ID: 30226125
[TBL] [Abstract][Full Text] [Related]
11. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.
Healey KM; Penn DL; Perkins D; Woods SW; Keefe RSE; Addington J
Schizophr Bull; 2018 Feb; 44(2):286-296. PubMed ID: 29036587
[TBL] [Abstract][Full Text] [Related]
12. Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
Zhang T; Wei Y; Cui H; Tang X; Xu L; Hu Y; Tang Y; Liu H; Chen T; Li C; Wang J
Psychiatry Res; 2023 Sep; 327():115385. PubMed ID: 37567111
[TBL] [Abstract][Full Text] [Related]
13. Neurocognition in help-seeking individuals at risk for psychosis: Prediction of outcome after 24 months.
Metzler S; Dvorsky D; Wyss C; Nordt C; Walitza S; Heekeren K; Rössler W; Theodoridou A
Psychiatry Res; 2016 Dec; 246():188-194. PubMed ID: 27718468
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
[TBL] [Abstract][Full Text] [Related]
15. The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
Kimhy D; Gill KE; Brucato G; Vakhrusheva J; Arndt L; Gross JJ; Girgis RR
Psychol Med; 2016 Oct; 46(14):2907-2918. PubMed ID: 27050714
[TBL] [Abstract][Full Text] [Related]
16. Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.
Sheffield JM; Karcher NR; Barch DM
Neuropsychol Rev; 2018 Dec; 28(4):509-533. PubMed ID: 30343458
[TBL] [Abstract][Full Text] [Related]
17. Self-Disorders and Clinical High Risk for Psychosis: An Empirical Study in Help-Seeking Youth Attending Community Mental Health Facilities.
Raballo A; Pappagallo E; Dell' Erba A; Lo Cascio N; Patane' M; Gebhardt E; Boldrini T; Terzariol L; Angelone M; Trisolini A; Girardi P; Fiori Nastro P
Schizophr Bull; 2016 Jul; 42(4):926-32. PubMed ID: 26757754
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
Khoury R; Nasrallah HA
Schizophr Res; 2018 Sep; 199():31-38. PubMed ID: 29703661
[TBL] [Abstract][Full Text] [Related]
19. Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis.
Carrión RE; Cornblatt BA; McLaughlin D; Chang J; Auther AM; Olsen RH; Javitt DC
Schizophr Res; 2015 May; 164(1-3):1-7. PubMed ID: 25728833
[TBL] [Abstract][Full Text] [Related]
20. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.
Devoe DJ; Lu L; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Walker EF; Mathalon DH; Bearden CE; Addington J
Schizophr Res; 2021 Jan; 227():28-37. PubMed ID: 32362460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
